| Stereochemistry | RACEMIC |
| Molecular Formula | C17H23NO.BrH |
| Molecular Weight | 338.283 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Br.CN1CC[C@]23CCCC[C@H]2[C@H]1CC4=CC=C(O)C=C34
InChI
InChIKey=WVFGKGPFQSEWON-DYWKTHLTSA-N
InChI=1S/C17H23NO.BrH/c1-18-9-8-17-7-3-2-4-14(17)16(18)10-12-5-6-13(19)11-15(12)17;/h5-6,11,14,16,19H,2-4,7-10H2,1H3;1H/t14-,16+,17+;/m0./s1
Racemorphan is racemic mixture of an antitussive and dissociative hallucinogen Dextrorphan and an opioid analgesic Levorphanol. Racemorphan itself is under international control per the Single Convention on Narcotic Drugs 1961 and is therefore listed as a Schedule II Narcotic controlled substance.
CNS Activity
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 2.3 nM [Ki] | |||
| 0.13 nM [Ki] | |||
| 4.2 nM [Ki] | |||
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Doses
AEs
Sourcing
ACTIVE MOIETY
SUBSTANCE RECORD
